In spite of the efficiency of these treatments, just a few melanoma patients have attained long-lasting clinical responses with monotherapy, so the combination with other immune checkpoint inhibitors, B-Raf/MEK inhibitors, or other treatments (e.g., chemotherapy, radiotherapy) has become the best option for the treatment of melanoma [89,90]. Here, MAP2K7 is linked to melanoma.